Collagen-Induced Arthritis Analysis in Rhbdf2 Knockout Mouse
Min-Young Lee1,2, Ju-Seong Kang1, Ryeo-Eun Go2
1Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Cheongwon 28116, Republic of Korea.
Biomolecules & Therapeutics
|December 11, 2017
Summary
Rhomboid family member 2 (Rhbdf2) gene knockout alleviates collagen-induced arthritis severity in mice. This study highlights Rhbdf2
Area of Science:
- Immunology
- Genetics
- Biochemistry
Background:
- Rhomboid family member 2 (Rhbdf2) is an inactive serine protease homolog.
- Rhbdf2 is crucial for the maturation of TNF-α converting enzyme, regulating TNF-α release.
- Tumor necrosis factor-alpha (TNF-α) plays a key role in inflammatory diseases like arthritis.
Purpose of the Study:
- To investigate the role of Rhbdf2 in collagen-induced arthritis (CIA) by generating Rhbdf2 knockout (KO) mice.
- To assess the impact of impaired TNF-α release on CIA development and severity.
- To evaluate physical function loss in CIA using grip strength and rota-rod tests.
Main Methods:
- CRISPR/Cas9 technology was used to generate Rhbdf2 KO mice.
- Collagen-induced arthritis (CIA) was induced in Rhbdf2 mutant mice using chicken collagen type II.
- Disease severity was assessed via clinical scores, histopathological analysis, rota-rod, and grip strength tests.
Main Results:
- Rhbdf2 KO mice exhibited significantly reduced clinical severity of CIA.
- Histopathological analysis confirmed the alleviation of arthritis in Rhbdf2 mutant mice.
- Grip strength testing proved effective in evaluating CIA-induced physical functional deficits.
Conclusions:
- The Rhbdf2 gene significantly influences the induction and severity of collagen-induced arthritis.
- Targeting Rhbdf2 may offer a therapeutic strategy for TNF-α related inflammatory diseases.
- Impaired TNF-α release due to Rhbdf2 deficiency ameliorates CIA pathogenesis.


